Current and historical daily PE Ratio for GSK (
GSK PLC
) from 1990 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. GSK PLC stock (GSK) PE ratio as of Apr 25 2024 is 14.68.
More Details
GSK PLC (GSK) PE Ratio (TTM) Chart
GSK PLC (GSK) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1215
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| GSK PLC PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-25 | 14.7 | 2024-02-21 | 15.1 |
| 2024-04-24 | 14.7 | 2024-02-20 | 15.1 |
| 2024-04-23 | 14.8 | 2024-02-16 | 15.1 |
| 2024-04-22 | 14.6 | 2024-02-15 | 15.0 |
| 2024-04-19 | 14.3 | 2024-02-14 | 15.0 |
| 2024-04-18 | 14.1 | 2024-02-13 | 14.9 |
| 2024-04-17 | 14.2 | 2024-02-12 | 14.8 |
| 2024-04-16 | 14.3 | 2024-02-09 | 15.1 |
| 2024-04-15 | 14.6 | 2024-02-08 | 15.0 |
| 2024-04-12 | 14.6 | 2024-02-07 | 15.1 |
| 2024-04-11 | 14.7 | 2024-02-06 | 15.0 |
| 2024-04-10 | 14.6 | 2024-02-05 | 14.9 |
| 2024-04-09 | 14.7 | 2024-02-02 | 14.6 |
| 2024-04-08 | 14.7 | 2024-02-01 | 14.6 |
| 2024-04-05 | 14.8 | 2024-01-31 | 14.2 |
| 2024-04-04 | 14.7 | 2024-01-30 | 14.0 |
| 2024-04-03 | 14.9 | 2024-01-29 | 14.0 |
| 2024-04-02 | 15.0 | 2024-01-26 | 14.0 |
| 2024-04-01 | 15.2 | 2024-01-25 | 13.9 |
| 2024-03-28 | 15.4 | 2024-01-24 | 14.0 |
| 2024-03-27 | 15.4 | 2024-01-23 | 14.1 |
| 2024-03-26 | 15.4 | 2024-01-22 | 14.2 |
| 2024-03-25 | 15.4 | 2024-01-19 | 14.3 |
| 2024-03-22 | 15.2 | 2024-01-18 | 14.2 |
| 2024-03-21 | 15.2 | 2024-01-17 | 14.3 |
| 2024-03-20 | 15.1 | 2024-01-16 | 14.3 |
| 2024-03-19 | 15.2 | 2024-01-12 | 14.4 |
| 2024-03-18 | 15.1 | 2024-01-11 | 14.2 |
| 2024-03-15 | 15.2 | 2024-01-10 | 14.4 |
| 2024-03-14 | 15.5 | 2024-01-09 | 14.3 |
| 2024-03-13 | 15.6 | 2024-01-08 | 14.2 |
| 2024-03-12 | 15.5 | 2024-01-05 | 14.1 |
| 2024-03-11 | 15.4 | 2024-01-04 | 14.0 |
| 2024-03-08 | 15.5 | 2024-01-03 | 14.0 |
| 2024-03-07 | 15.7 | 2024-01-02 | 13.5 |
| 2024-03-06 | 15.3 | 2023-12-29 | 13.3 |
| 2024-03-05 | 15.3 | 2023-12-28 | 13.3 |
| 2024-03-04 | 15.2 | 2023-12-27 | 10.7 |
| 2024-03-01 | 15.1 | 2023-12-26 | 10.7 |
| 2024-02-29 | 15.1 | 2023-12-22 | 10.7 |
| 2024-02-28 | 15.2 | 2023-12-21 | 10.6 |
| 2024-02-27 | 15.2 | 2023-12-20 | 10.5 |
| 2024-02-26 | 15.2 | 2023-12-19 | 10.6 |
| 2024-02-23 | 15.2 | 2023-12-18 | 10.5 |
| 2024-02-22 | 15.1 | 2023-12-15 | 10.4 |
GSK PLC (GSK) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
GSK PLC
NAICS : 325412
SIC : 2834
ISIN : US37733W1053
Share Class Description:
GSK: ADRCompare
Compare
Traded in other countries / regions
GSK.UKGSK.USAGS71.GermanyGSK1.MexicoGSK.ArgentinaG1SK34.Brazil IPO Date
1987-06-10Description
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers